Resources Contact Us Home
Modified leukotoxin protein

Image Number 10 for United States Patent #7790170.

The present invention provides nucleic acid sequences encoding a modified leukotoxin protein, wherein the modification comprises the removal of nucleic acid sequences encoding amino acids within hydrophobic transmembrane domains of full length leukotoxin protein, preferably from Mannheimia haemolytica. The modified leukotoxin proteins are useful in vaccine compositions effective against Mannheimia haemolytica in animals.

  Recently Added Patents
Methods and compositions for inhibition of neutrophil exocytosis
Analysis of methylation using nucleic acid arrays
Process information structuring support method
Encoding and/or decoding memory devices and methods thereof
Cytokine receptors associated with myelogenous haematological proliferative disorders and uses thereof
Wire guide
Semiconductor device
  Randomly Featured Patents
Key management using quasi out of band authentication architecture
Method for forming products from a flue gas desulfurization by-product and products formed thereby
Outdoor floodlight extender
Stadium seating adjustable storage device
System and method for editing an image stream captured in-vivo
Monolithic microwave integrated circuit providing power dividing and power monitoring functionality
Ink-jet printer
Variable movement headrest arrangement
Rigid composite structure with a superhard interior surface
Anticipatory changes to resources managed by locks